Compare Johnson & Johnson (JNJ) vs RingCentral Inc. Class A Common Stock (RNG) Price & Performance

Johnson & JohnsonTrade

RingCentral Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Johnson & Johnson vs RingCentral Inc. Class A Common Stock — how do they compare? Johnson & Johnson trades at $261.08 (market cap $618.09B), while RingCentral Inc. Class A Common Stock trades at $79.35 (market cap $6.54B). The key difference: Johnson & Johnson is far larger — about 94.5× RingCentral Inc. Class A Common Stock's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and RingCentral Inc. Class A Common Stock for 0 Days on average.

	JNJ	RNG
Market Cap	$618.09B	$6.54B
Volume	6,050,983	1,543,570
Sector	Health	Technology
52-Week High	$278.43	$79.82
52-Week Low	$186.00	$24.82
Typical Hold Time	129 Days	0 Days
Enterprise Value	$646.37B	$7.60B
Dividend Yield	2.09%	0.35%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $259.62, up 0.45% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 21.48% net margin and 25.74% ROE, though valuation ratios appear elevated with P/E at 29.75. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with 52.5% buy ratings.

JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and increasing debt-to-asset ratio (24.06% in 2025). Analyst consensus target of $286.53 suggests 10% upside potential, though technical resistance at $260 may limit near-term gains.

RingCentral Inc. Class A Common Stock

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JNJ

96% Buy4% Sell

Avg holding period · 129 Days

RNG

100% Buy0% Sell

Avg holding period · 0 Days

Top news

Latest headlines on both assets

JNJ

Johnson & Johnson Q3 earnings expected with 5% EPS drop but 5.8% revenue growthGordon Thompson · 6 hours agoNeutral Four Dividend Kings remain strong but PepsiCo's dividend payout is riskier than others.24/7 Wall Street · 8 hours agoNeutral New Phase 3 data show ICOTYDE provides lasting skin clearance in moderate-to-severe plaque psoriasis over two years.PRNewsWire · 10 hours agoBullish View details →

RNG

Investigation launched into RingCentral for possible fiduciary breaches affecting shareholders.PRNewsWire · 21 hours agoBearish View details →

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

About RingCentral Inc. Class A Common Stock

RingCentral provides cloud-based business communications and contact center solutions. Its platform combines phone, messaging, video meetings, and customer-service tools.